Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 8.32057234 |
2 | * viral transcription (GO:0019083) | 7.50299408 |
3 | * translational termination (GO:0006415) | 7.25723057 |
4 | ribosomal small subunit biogenesis (GO:0042274) | 6.76082379 |
5 | maturation of SSU-rRNA (GO:0030490) | 6.53080537 |
6 | * translational elongation (GO:0006414) | 6.35216141 |
7 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.26968101 |
8 | * cotranslational protein targeting to membrane (GO:0006613) | 6.13344001 |
9 | * protein targeting to ER (GO:0045047) | 6.11932816 |
10 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.82754271 |
11 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.77069513 |
12 | * protein localization to endoplasmic reticulum (GO:0070972) | 5.73687547 |
13 | * translational initiation (GO:0006413) | 5.66312598 |
14 | * cellular protein complex disassembly (GO:0043624) | 5.62486193 |
15 | * viral life cycle (GO:0019058) | 5.61189971 |
16 | * ribosomal large subunit biogenesis (GO:0042273) | 5.11008573 |
17 | * protein complex disassembly (GO:0043241) | 4.96243172 |
18 | * macromolecular complex disassembly (GO:0032984) | 4.67893913 |
19 | DNA deamination (GO:0045006) | 4.60339604 |
20 | formation of translation preinitiation complex (GO:0001731) | 4.52203162 |
21 | * ribonucleoprotein complex biogenesis (GO:0022613) | 4.46583539 |
22 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.41671715 |
23 | * translation (GO:0006412) | 4.36646605 |
24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.33866478 |
25 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.33438684 |
26 | regulation of translational fidelity (GO:0006450) | 4.25856222 |
27 | DNA strand elongation (GO:0022616) | 4.20967860 |
28 | * mRNA catabolic process (GO:0006402) | 4.11737704 |
29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.07971789 |
30 | * protein targeting to membrane (GO:0006612) | 3.99282607 |
31 | DNA replication initiation (GO:0006270) | 3.93378625 |
32 | * RNA catabolic process (GO:0006401) | 3.92591478 |
33 | * rRNA processing (GO:0006364) | 3.82042100 |
34 | telomere maintenance via recombination (GO:0000722) | 3.81740535 |
35 | ATP synthesis coupled proton transport (GO:0015986) | 3.71074702 |
36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.71074702 |
37 | * rRNA metabolic process (GO:0016072) | 3.68959308 |
38 | DNA unwinding involved in DNA replication (GO:0006268) | 3.66185440 |
39 | DNA replication checkpoint (GO:0000076) | 3.62317234 |
40 | nuclear pore complex assembly (GO:0051292) | 3.59821849 |
41 | mitotic recombination (GO:0006312) | 3.55487771 |
42 | nucleobase biosynthetic process (GO:0046112) | 3.54846828 |
43 | telomere maintenance via telomere lengthening (GO:0010833) | 3.50005509 |
44 | * cellular component biogenesis (GO:0044085) | 3.44800780 |
45 | CENP-A containing nucleosome assembly (GO:0034080) | 3.43297874 |
46 | chromatin remodeling at centromere (GO:0031055) | 3.42771602 |
47 | ribosome biogenesis (GO:0042254) | 3.41889696 |
48 | * protein targeting (GO:0006605) | 3.40706993 |
49 | pseudouridine synthesis (GO:0001522) | 3.38696816 |
50 | * establishment of protein localization to organelle (GO:0072594) | 3.37867509 |
51 | mitotic chromosome condensation (GO:0007076) | 3.31729400 |
52 | spliceosomal snRNP assembly (GO:0000387) | 3.31549116 |
53 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.31310974 |
54 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.28735603 |
55 | purine nucleobase biosynthetic process (GO:0009113) | 3.28107662 |
56 | proteasome assembly (GO:0043248) | 3.24326034 |
57 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.22527328 |
58 | IMP biosynthetic process (GO:0006188) | 3.14420654 |
59 | nuclear pore organization (GO:0006999) | 3.09749407 |
60 | termination of RNA polymerase III transcription (GO:0006386) | 3.08799147 |
61 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08799147 |
62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.06022924 |
63 | chaperone-mediated protein transport (GO:0072321) | 3.05644418 |
64 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.05016711 |
65 | DNA replication-independent nucleosome organization (GO:0034724) | 3.05016711 |
66 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.04515341 |
67 | protein localization to kinetochore (GO:0034501) | 3.03126236 |
68 | kinetochore organization (GO:0051383) | 3.01858076 |
69 | heterochromatin organization (GO:0070828) | 3.01588906 |
70 | spliceosomal complex assembly (GO:0000245) | 2.99541196 |
71 | mitotic metaphase plate congression (GO:0007080) | 2.99383422 |
72 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.94986627 |
73 | viral mRNA export from host cell nucleus (GO:0046784) | 2.94274421 |
74 | rRNA modification (GO:0000154) | 2.92187497 |
75 | ribonucleoprotein complex assembly (GO:0022618) | 2.91483611 |
76 | oxidative phosphorylation (GO:0006119) | 2.91470192 |
77 | ribosome assembly (GO:0042255) | 2.90839109 |
78 | establishment of integrated proviral latency (GO:0075713) | 2.88502624 |
79 | DNA topological change (GO:0006265) | 2.88485123 |
80 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.87783345 |
81 | * protein localization to membrane (GO:0072657) | 2.87740244 |
82 | * gene expression (GO:0010467) | 2.87001696 |
83 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.86672724 |
84 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.86657460 |
85 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.86313375 |
86 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.86111195 |
87 | ncRNA 3-end processing (GO:0043628) | 2.84994760 |
88 | mitotic nuclear envelope disassembly (GO:0007077) | 2.83702574 |
89 | * ncRNA processing (GO:0034470) | 2.82058572 |
90 | IMP metabolic process (GO:0046040) | 2.81226397 |
91 | negative regulation of ligase activity (GO:0051352) | 2.81028850 |
92 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.81028850 |
93 | kinetochore assembly (GO:0051382) | 2.80833788 |
94 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.80538302 |
95 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.80315254 |
96 | regulation of mitochondrial translation (GO:0070129) | 2.79348420 |
97 | negative regulation of mRNA processing (GO:0050686) | 2.78605722 |
98 | proline biosynthetic process (GO:0006561) | 2.78200189 |
99 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.77065613 |
100 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.77065613 |
101 | mitotic sister chromatid segregation (GO:0000070) | 2.75777850 |
102 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.75145554 |
103 | ribonucleoprotein complex subunit organization (GO:0071826) | 2.74940696 |
104 | protein targeting to mitochondrion (GO:0006626) | 2.74746731 |
105 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.73550681 |
106 | termination of RNA polymerase I transcription (GO:0006363) | 2.72263919 |
107 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.71641761 |
108 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.71641761 |
109 | metaphase plate congression (GO:0051310) | 2.70945192 |
110 | * establishment of protein localization to membrane (GO:0090150) | 2.70922968 |
111 | negative regulation of RNA splicing (GO:0033119) | 2.70094125 |
112 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.69126187 |
113 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.69126187 |
114 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.69126187 |
115 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.68156842 |
116 | cell cycle G1/S phase transition (GO:0044843) | 2.68156842 |
117 | mRNA splicing, via spliceosome (GO:0000398) | 2.67609029 |
118 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.67609029 |
119 | * ncRNA metabolic process (GO:0034660) | 2.67287459 |
120 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66481929 |
121 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66481929 |
122 | telomere organization (GO:0032200) | 2.65884010 |
123 | telomere maintenance (GO:0000723) | 2.65750468 |
124 | protein localization to chromosome, centromeric region (GO:0071459) | 2.65228355 |
125 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.64673110 |
126 | histone exchange (GO:0043486) | 2.64406401 |
127 | RNA splicing, via transesterification reactions (GO:0000375) | 2.62815418 |
128 | pore complex assembly (GO:0046931) | 2.61661078 |
129 | negative regulation of mRNA metabolic process (GO:1903312) | 2.58455915 |
130 | tRNA aminoacylation for protein translation (GO:0006418) | 2.58074808 |
131 | * cellular component disassembly (GO:0022411) | 2.57106155 |
132 | amino acid activation (GO:0043038) | 2.56996329 |
133 | tRNA aminoacylation (GO:0043039) | 2.56996329 |
134 | sister chromatid segregation (GO:0000819) | 2.55146045 |
135 | * protein localization to organelle (GO:0033365) | 2.53679192 |
136 | termination of RNA polymerase II transcription (GO:0006369) | 2.51449595 |
137 | establishment of protein localization to mitochondrion (GO:0072655) | 2.49259519 |
138 | regulation of translational elongation (GO:0006448) | 2.48668699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.38806306 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.63651947 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.00950681 |
4 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.24602102 |
5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.24144205 |
6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.23297728 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.17614008 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.14465159 |
9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09662193 |
10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.02298072 |
11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.95610857 |
12 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90988579 |
13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.84943172 |
14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.79641251 |
15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.75149245 |
16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.74222991 |
17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.72262716 |
18 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.54338533 |
19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.42664565 |
20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.38167545 |
21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37764003 |
22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.28626096 |
23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.25065789 |
24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16719573 |
25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10035588 |
26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.09931116 |
27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08398538 |
28 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.06253931 |
29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.02575506 |
30 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98886381 |
31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.83652054 |
32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.82182135 |
33 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.81258061 |
34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.79623035 |
35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79117768 |
36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.77113972 |
37 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65270536 |
38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65224699 |
39 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64552218 |
40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62617305 |
41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62258638 |
42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61596388 |
43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58715867 |
44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58396036 |
45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57438121 |
46 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.56239755 |
47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54001383 |
48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53161765 |
49 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.51020447 |
50 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51019773 |
51 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50359812 |
52 | MYC_22102868_ChIP-Seq_BL_Human | 1.49116403 |
53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48337752 |
54 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48240484 |
55 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43138450 |
56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42625723 |
57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38495422 |
58 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38245895 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26498088 |
60 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26431755 |
61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21950216 |
62 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21842041 |
63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21386882 |
64 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21214290 |
65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21141327 |
66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19974534 |
67 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.19518382 |
68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17967564 |
69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17343455 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15971279 |
71 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15724712 |
72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12985239 |
73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12599401 |
74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09916421 |
75 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09298764 |
76 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08356340 |
77 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07137978 |
78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.06983811 |
79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06820418 |
80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05062003 |
81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03314834 |
82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03205223 |
83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03147550 |
84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02083545 |
85 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01624292 |
86 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01141923 |
87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00956648 |
88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00691674 |
89 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00138887 |
90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99889953 |
91 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99389606 |
92 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.98132593 |
93 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97980665 |
94 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97872607 |
95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97046348 |
96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96868110 |
97 | MAF_26560356_Chip-Seq_TH2_Human | 0.96641732 |
98 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95571291 |
99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94817845 |
100 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94145745 |
101 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94077339 |
102 | MAF_26560356_Chip-Seq_TH1_Human | 0.93351929 |
103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92254456 |
104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88003019 |
105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87057193 |
106 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86964415 |
107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86653177 |
108 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85149217 |
109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84906235 |
110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84373734 |
111 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.84250698 |
112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83867825 |
113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.79289716 |
114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78577859 |
115 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78310462 |
116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77341890 |
117 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.76543299 |
118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75774731 |
119 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74487342 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.89928427 |
2 | MP0004957_abnormal_blastocyst_morpholog | 4.13076556 |
3 | MP0010094_abnormal_chromosome_stability | 3.80864030 |
4 | MP0009379_abnormal_foot_pigmentation | 3.65071766 |
5 | MP0003111_abnormal_nucleus_morphology | 3.54644044 |
6 | MP0003077_abnormal_cell_cycle | 3.46197201 |
7 | MP0008057_abnormal_DNA_replication | 3.19208234 |
8 | MP0002396_abnormal_hematopoietic_system | 3.02523543 |
9 | MP0008058_abnormal_DNA_repair | 2.89060855 |
10 | MP0008007_abnormal_cellular_replicative | 2.60532780 |
11 | MP0003123_paternal_imprinting | 2.36564679 |
12 | MP0008932_abnormal_embryonic_tissue | 2.28711591 |
13 | MP0000490_abnormal_crypts_of | 2.16272806 |
14 | MP0003786_premature_aging | 2.00312228 |
15 | MP0003763_abnormal_thymus_physiology | 1.89066271 |
16 | MP0000350_abnormal_cell_proliferation | 1.79901507 |
17 | MP0004808_abnormal_hematopoietic_stem | 1.76552942 |
18 | MP0009333_abnormal_splenocyte_physiolog | 1.75549765 |
19 | MP0001730_embryonic_growth_arrest | 1.72047736 |
20 | MP0010352_gastrointestinal_tract_polyps | 1.68255855 |
21 | MP0005397_hematopoietic_system_phenotyp | 1.57925450 |
22 | MP0001545_abnormal_hematopoietic_system | 1.57925450 |
23 | MP0002132_abnormal_respiratory_system | 1.56217128 |
24 | MP0002877_abnormal_melanocyte_morpholog | 1.55908701 |
25 | MP0006054_spinal_hemorrhage | 1.53368487 |
26 | MP0004185_abnormal_adipocyte_glucose | 1.49537881 |
27 | MP0000678_abnormal_parathyroid_gland | 1.48692541 |
28 | MP0002019_abnormal_tumor_incidence | 1.41797814 |
29 | MP0002796_impaired_skin_barrier | 1.41548908 |
30 | MP0002398_abnormal_bone_marrow | 1.40404361 |
31 | MP0003567_abnormal_fetal_cardiomyocyte | 1.38688821 |
32 | MP0001835_abnormal_antigen_presentation | 1.38682335 |
33 | MP0000313_abnormal_cell_death | 1.37560345 |
34 | MP0005174_abnormal_tail_pigmentation | 1.33406981 |
35 | MP0001697_abnormal_embryo_size | 1.28705184 |
36 | MP0002722_abnormal_immune_system | 1.27983508 |
37 | MP0000703_abnormal_thymus_morphology | 1.26871937 |
38 | MP0002080_prenatal_lethality | 1.24536612 |
39 | MP0003186_abnormal_redox_activity | 1.23687989 |
40 | MP0008877_abnormal_DNA_methylation | 1.22403468 |
41 | MP0003315_abnormal_perineum_morphology | 1.21343687 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.20584404 |
43 | MP0000689_abnormal_spleen_morphology | 1.20231135 |
44 | MP0001672_abnormal_embryogenesis/_devel | 1.17180866 |
45 | MP0005380_embryogenesis_phenotype | 1.17180866 |
46 | MP0005408_hypopigmentation | 1.14942250 |
47 | MP0009672_abnormal_birth_weight | 1.14113795 |
48 | MP0002429_abnormal_blood_cell | 1.13781910 |
49 | MP0001348_abnormal_lacrimal_gland | 1.11796255 |
50 | MP0002095_abnormal_skin_pigmentation | 1.11619025 |
51 | MP0005671_abnormal_response_to | 1.10762789 |
52 | MP0003718_maternal_effect | 1.10744202 |
53 | MP0002166_altered_tumor_susceptibility | 1.08435709 |
54 | MP0001881_abnormal_mammary_gland | 1.08007576 |
55 | MP0006035_abnormal_mitochondrial_morpho | 1.07762884 |
56 | MP0010307_abnormal_tumor_latency | 1.06834039 |
57 | MP0000685_abnormal_immune_system | 1.06720102 |
58 | MP0003984_embryonic_growth_retardation | 1.06607767 |
59 | MP0000858_altered_metastatic_potential | 1.06439276 |
60 | MP0001853_heart_inflammation | 1.06419342 |
61 | MP0001800_abnormal_humoral_immune | 1.05992425 |
62 | MP0000716_abnormal_immune_system | 1.03922297 |
63 | MP0002088_abnormal_embryonic_growth/wei | 1.03795954 |
64 | MP0002006_tumorigenesis | 1.03594499 |
65 | MP0009697_abnormal_copulation | 1.03247194 |
66 | MP0003941_abnormal_skin_development | 1.02735539 |
67 | MP0002086_abnormal_extraembryonic_tissu | 1.02578431 |
68 | MP0002085_abnormal_embryonic_tissue | 1.01387958 |
69 | MP0005451_abnormal_body_composition | 1.01334351 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.01300647 |
71 | MP0002420_abnormal_adaptive_immunity | 1.00783929 |
72 | MP0010155_abnormal_intestine_physiology | 1.00312284 |
73 | MP0001819_abnormal_immune_cell | 0.98792839 |
74 | MP0003806_abnormal_nucleotide_metabolis | 0.98778880 |
75 | MP0003121_genomic_imprinting | 0.96734343 |
76 | MP0002938_white_spotting | 0.96150630 |
77 | MP0002452_abnormal_antigen_presenting | 0.94289893 |
78 | MP0010030_abnormal_orbit_morphology | 0.94058929 |
79 | MP0002160_abnormal_reproductive_system | 0.93661411 |
80 | MP0009785_altered_susceptibility_to | 0.93314836 |
81 | MP0003705_abnormal_hypodermis_morpholog | 0.92663939 |
82 | MP0004197_abnormal_fetal_growth/weight/ | 0.91905151 |
83 | MP0001293_anophthalmia | 0.91391029 |
84 | MP0002405_respiratory_system_inflammati | 0.89997819 |
85 | MP0003866_abnormal_defecation | 0.89308381 |
86 | MP0002084_abnormal_developmental_patter | 0.89192757 |
87 | MP0001727_abnormal_embryo_implantation | 0.88770352 |
88 | MP0002148_abnormal_hypersensitivity_rea | 0.87899602 |
89 | MP0004233_abnormal_muscle_weight | 0.86657724 |
90 | MP0005025_abnormal_response_to | 0.86329988 |
91 | MP0005501_abnormal_skin_physiology | 0.86103091 |
92 | MP0002723_abnormal_immune_serum | 0.86061489 |
93 | MP0001873_stomach_inflammation | 0.84867927 |
94 | MP0002210_abnormal_sex_determination | 0.81808568 |
95 | MP0000477_abnormal_intestine_morphology | 0.81714120 |
96 | MP0006036_abnormal_mitochondrial_physio | 0.80426152 |
97 | MP0000358_abnormal_cell_content/ | 0.77805572 |
98 | MP0005076_abnormal_cell_differentiation | 0.77668452 |
99 | MP0004147_increased_porphyrin_level | 0.77319415 |
100 | MP0003436_decreased_susceptibility_to | 0.76969903 |
101 | MP0005000_abnormal_immune_tolerance | 0.76906755 |
102 | MP0001661_extended_life_span | 0.76822380 |
103 | MP0010234_abnormal_vibrissa_follicle | 0.74611973 |
104 | MP0006292_abnormal_olfactory_placode | 0.74139758 |
105 | MP0005023_abnormal_wound_healing | 0.73747259 |
106 | MP0001145_abnormal_male_reproductive | 0.72595215 |
107 | MP0000537_abnormal_urethra_morphology | 0.71683974 |
108 | MP0004381_abnormal_hair_follicle | 0.67568243 |
109 | MP0001346_abnormal_lacrimal_gland | 0.67458150 |
110 | MP0002163_abnormal_gland_morphology | 0.66530085 |
111 | MP0005666_abnormal_adipose_tissue | 0.66084729 |
112 | MP0004264_abnormal_extraembryonic_tissu | 0.62287972 |
113 | MP0008995_early_reproductive_senescence | 0.61800560 |
114 | MP0002111_abnormal_tail_morphology | 0.60844650 |
115 | MP0001286_abnormal_eye_development | 0.60090146 |
116 | MP0009278_abnormal_bone_marrow | 0.60034280 |
117 | MP0009931_abnormal_skin_appearance | 0.59883198 |
118 | MP0000653_abnormal_sex_gland | 0.59670460 |
119 | MP0002697_abnormal_eye_size | 0.59278851 |
120 | MP0000627_abnormal_mammary_gland | 0.58401797 |
121 | MP0000372_irregular_coat_pigmentation | 0.57972619 |
122 | MP0001119_abnormal_female_reproductive | 0.57812878 |
123 | MP0009053_abnormal_anal_canal | 0.56747893 |
124 | MP0001929_abnormal_gametogenesis | 0.56447865 |
125 | MP0000428_abnormal_craniofacial_morphol | 0.55100992 |
126 | MP0002009_preneoplasia | 0.53819732 |
127 | MP0005384_cellular_phenotype | 0.53567036 |
128 | MP0004133_heterotaxia | 0.52248546 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.74427459 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 7.18246212 |
3 | Reticulocytopenia (HP:0001896) | 7.06728469 |
4 | Macrocytic anemia (HP:0001972) | 5.09571552 |
5 | Pallor (HP:0000980) | 4.83599730 |
6 | Aplastic anemia (HP:0001915) | 4.22949680 |
7 | Colon cancer (HP:0003003) | 3.87692524 |
8 | Thrombocytosis (HP:0001894) | 3.82230729 |
9 | Birth length less than 3rd percentile (HP:0003561) | 3.71865605 |
10 | Oral leukoplakia (HP:0002745) | 3.63441327 |
11 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.60527786 |
12 | 11 pairs of ribs (HP:0000878) | 3.45885145 |
13 | Progressive muscle weakness (HP:0003323) | 3.09477153 |
14 | Absent thumb (HP:0009777) | 2.99741497 |
15 | Breast hypoplasia (HP:0003187) | 2.93716805 |
16 | Rough bone trabeculation (HP:0100670) | 2.85001708 |
17 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71150523 |
18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68610525 |
19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68610525 |
20 | Trismus (HP:0000211) | 2.63274626 |
21 | Selective tooth agenesis (HP:0001592) | 2.60750958 |
22 | Chromsome breakage (HP:0040012) | 2.59568971 |
23 | Myelodysplasia (HP:0002863) | 2.56202509 |
24 | Abnormality of the preputium (HP:0100587) | 2.55729075 |
25 | Abnormality of reticulocytes (HP:0004312) | 2.47018099 |
26 | Type I transferrin isoform profile (HP:0003642) | 2.45771802 |
27 | Progressive external ophthalmoplegia (HP:0000590) | 2.45145106 |
28 | Multiple enchondromatosis (HP:0005701) | 2.43867576 |
29 | Abnormal hemoglobin (HP:0011902) | 2.42046556 |
30 | Acute encephalopathy (HP:0006846) | 2.41923843 |
31 | Exertional dyspnea (HP:0002875) | 2.40917259 |
32 | Hepatocellular necrosis (HP:0001404) | 2.40405238 |
33 | Testicular atrophy (HP:0000029) | 2.38340124 |
34 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37981087 |
35 | IgM deficiency (HP:0002850) | 2.37932809 |
36 | Seborrheic dermatitis (HP:0001051) | 2.35514916 |
37 | Premature graying of hair (HP:0002216) | 2.35053708 |
38 | Microretrognathia (HP:0000308) | 2.34336703 |
39 | Carpal bone hypoplasia (HP:0001498) | 2.33722928 |
40 | Mitochondrial inheritance (HP:0001427) | 2.32341070 |
41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.32085852 |
42 | Patellar aplasia (HP:0006443) | 2.32029919 |
43 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31906955 |
44 | Abnormality of glycolysis (HP:0004366) | 2.30955001 |
45 | Abnormality of the anterior horn cell (HP:0006802) | 2.30775095 |
46 | Degeneration of anterior horn cells (HP:0002398) | 2.30775095 |
47 | Triphalangeal thumb (HP:0001199) | 2.28625909 |
48 | Meckel diverticulum (HP:0002245) | 2.28612385 |
49 | Pancytopenia (HP:0001876) | 2.24130862 |
50 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.22483985 |
51 | Asplenia (HP:0001746) | 2.22342643 |
52 | Abnormality of chromosome stability (HP:0003220) | 2.22162012 |
53 | Hypertensive crisis (HP:0100735) | 2.22003921 |
54 | Depressed nasal ridge (HP:0000457) | 2.20609650 |
55 | Increased serum pyruvate (HP:0003542) | 2.19719612 |
56 | Increased CSF lactate (HP:0002490) | 2.19524262 |
57 | Hyperthyroidism (HP:0000836) | 2.18399849 |
58 | Abnormality of the ileum (HP:0001549) | 2.16954819 |
59 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.16862424 |
60 | Hypoplasia of the radius (HP:0002984) | 2.16430312 |
61 | Neoplasm of the pancreas (HP:0002894) | 2.16185701 |
62 | Short middle phalanx of the 5th finger (HP:0004220) | 2.15825468 |
63 | Increased serum lactate (HP:0002151) | 2.15625013 |
64 | Stenosis of the external auditory canal (HP:0000402) | 2.12258945 |
65 | Respiratory difficulties (HP:0002880) | 2.11547457 |
66 | Petechiae (HP:0000967) | 2.11275396 |
67 | Hepatic necrosis (HP:0002605) | 2.09489470 |
68 | Homocystinuria (HP:0002156) | 2.08724727 |
69 | Abnormality of homocysteine metabolism (HP:0010919) | 2.08724727 |
70 | Medulloblastoma (HP:0002885) | 2.08159650 |
71 | Autoimmune hemolytic anemia (HP:0001890) | 2.07565490 |
72 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07384319 |
73 | Missing ribs (HP:0000921) | 2.06914099 |
74 | Bone marrow hypocellularity (HP:0005528) | 2.06607266 |
75 | Cleft eyelid (HP:0000625) | 2.05766175 |
76 | Cerebral hypomyelination (HP:0006808) | 2.05234343 |
77 | Abnormal trabecular bone morphology (HP:0100671) | 2.04600609 |
78 | Glossoptosis (HP:0000162) | 2.01655738 |
79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.01489136 |
80 | Increased muscle lipid content (HP:0009058) | 2.00792197 |
81 | Lymphoma (HP:0002665) | 2.00467609 |
82 | Gout (HP:0001997) | 2.00112120 |
83 | Truncus arteriosus (HP:0001660) | 1.99920930 |
84 | Atresia of the external auditory canal (HP:0000413) | 1.99724091 |
85 | Cerebral edema (HP:0002181) | 1.96801374 |
86 | Abnormal number of incisors (HP:0011064) | 1.96262790 |
87 | Agnosia (HP:0010524) | 1.96206234 |
88 | Basal cell carcinoma (HP:0002671) | 1.95956099 |
89 | Cellular immunodeficiency (HP:0005374) | 1.95870635 |
90 | Sparse eyelashes (HP:0000653) | 1.95100455 |
91 | Poikiloderma (HP:0001029) | 1.93989113 |
92 | Acute necrotizing encephalopathy (HP:0006965) | 1.93459950 |
93 | Congenital, generalized hypertrichosis (HP:0004540) | 1.93283017 |
94 | Horseshoe kidney (HP:0000085) | 1.93207170 |
95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93107243 |
96 | Progressive macrocephaly (HP:0004481) | 1.91222612 |
97 | Abnormality of T cell physiology (HP:0011840) | 1.90966561 |
98 | Hypoparathyroidism (HP:0000829) | 1.90289449 |
99 | Exercise intolerance (HP:0003546) | 1.90106516 |
100 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.89748327 |
101 | Microvesicular hepatic steatosis (HP:0001414) | 1.89600161 |
102 | Small intestinal stenosis (HP:0012848) | 1.89491814 |
103 | Duodenal stenosis (HP:0100867) | 1.89491814 |
104 | Abnormality of cochlea (HP:0000375) | 1.88802367 |
105 | Amaurosis fugax (HP:0100576) | 1.87579220 |
106 | Tracheoesophageal fistula (HP:0002575) | 1.86911622 |
107 | Agammaglobulinemia (HP:0004432) | 1.84349811 |
108 | Lactic acidosis (HP:0003128) | 1.81324004 |
109 | Villous atrophy (HP:0011473) | 1.80947596 |
110 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80947596 |
111 | Thick lower lip vermilion (HP:0000179) | 1.80928254 |
112 | Abnormal lung lobation (HP:0002101) | 1.79434634 |
113 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79332607 |
114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77895614 |
115 | Neoplasm of the colon (HP:0100273) | 1.77684149 |
116 | Reticulocytosis (HP:0001923) | 1.75802392 |
117 | 3-Methylglutaconic aciduria (HP:0003535) | 1.74679306 |
118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73193906 |
119 | Squamous cell carcinoma (HP:0002860) | 1.72695449 |
120 | Muscle fiber atrophy (HP:0100295) | 1.72092002 |
121 | Increased nuchal translucency (HP:0010880) | 1.71327862 |
122 | Migraine (HP:0002076) | 1.71076838 |
123 | Secondary amenorrhea (HP:0000869) | 1.70678115 |
124 | Abnormality of methionine metabolism (HP:0010901) | 1.69500986 |
125 | Rhabdomyosarcoma (HP:0002859) | 1.68262408 |
126 | Pulmonary fibrosis (HP:0002206) | 1.66708595 |
127 | Renal Fanconi syndrome (HP:0001994) | 1.66003425 |
128 | Neoplasm of head and neck (HP:0012288) | 1.65469803 |
129 | Esophageal neoplasm (HP:0100751) | 1.65469803 |
130 | Premature ovarian failure (HP:0008209) | 1.65280695 |
131 | Acute lymphatic leukemia (HP:0006721) | 1.64982150 |
132 | Absent radius (HP:0003974) | 1.64831376 |
133 | Premature skin wrinkling (HP:0100678) | 1.64800167 |
134 | Abnormal glycosylation (HP:0012345) | 1.64487452 |
135 | Abnormality of the fingertips (HP:0001211) | 1.62748664 |
136 | Deep palmar crease (HP:0006191) | 1.62337352 |
137 | Gastrointestinal stroma tumor (HP:0100723) | 1.61501776 |
138 | Acute myeloid leukemia (HP:0004808) | 1.60981558 |
139 | Panhypogammaglobulinemia (HP:0003139) | 1.60135343 |
140 | Megaloblastic anemia (HP:0001889) | 1.59284852 |
141 | Ragged-red muscle fibers (HP:0003200) | 1.58623545 |
142 | Sparse lateral eyebrow (HP:0005338) | 1.57699523 |
143 | Abnormality of DNA repair (HP:0003254) | 1.56930845 |
144 | Nasolacrimal duct obstruction (HP:0000579) | 1.55673449 |
145 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.54995789 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.28319625 |
2 | BUB1 | 3.78299102 |
3 | WEE1 | 3.76503466 |
4 | EIF2AK1 | 2.99060840 |
5 | TLK1 | 2.97058451 |
6 | SMG1 | 2.89931175 |
7 | CDC7 | 2.88422019 |
8 | VRK2 | 2.88089148 |
9 | STK16 | 2.59445565 |
10 | SRPK1 | 2.34201098 |
11 | VRK1 | 2.20253210 |
12 | RPS6KB2 | 2.14300887 |
13 | NEK2 | 1.96678777 |
14 | BRSK2 | 1.93515749 |
15 | PASK | 1.91720399 |
16 | PIM2 | 1.86155061 |
17 | EIF2AK3 | 1.83935550 |
18 | TSSK6 | 1.83440646 |
19 | ACVR1B | 1.81288569 |
20 | PRPF4B | 1.79327782 |
21 | TGFBR1 | 1.74699254 |
22 | TRIB3 | 1.73047999 |
23 | MKNK1 | 1.70482837 |
24 | DYRK3 | 1.68847696 |
25 | ICK | 1.68545513 |
26 | AURKB | 1.56848429 |
27 | MAP4K1 | 1.53419725 |
28 | RPS6KA4 | 1.52088892 |
29 | PLK1 | 1.51065373 |
30 | MST4 | 1.50486089 |
31 | CDK7 | 1.50156488 |
32 | LRRK2 | 1.45096236 |
33 | TTK | 1.43779595 |
34 | EEF2K | 1.41628646 |
35 | CDK12 | 1.38845794 |
36 | ATR | 1.34457029 |
37 | TESK2 | 1.30786505 |
38 | PLK4 | 1.28416792 |
39 | TEC | 1.28254881 |
40 | SCYL2 | 1.25379175 |
41 | FLT3 | 1.23050892 |
42 | MKNK2 | 1.21780299 |
43 | NEK1 | 1.14251285 |
44 | TAF1 | 1.13081027 |
45 | CDK4 | 1.12734776 |
46 | ILK | 1.11454893 |
47 | PDK2 | 1.10910142 |
48 | MAP3K8 | 1.04337752 |
49 | NME1 | 1.01576670 |
50 | AURKA | 1.01010801 |
51 | PIM1 | 0.99734083 |
52 | IRAK3 | 0.99703894 |
53 | STK10 | 0.99421771 |
54 | BTK | 0.99366737 |
55 | MAP3K10 | 0.98700837 |
56 | KDR | 0.98239781 |
57 | MAP2K3 | 0.97340034 |
58 | ZAK | 0.93932899 |
59 | CDK19 | 0.92792834 |
60 | CDK8 | 0.91787793 |
61 | BRSK1 | 0.91291639 |
62 | CHEK2 | 0.89703539 |
63 | PLK3 | 0.88506391 |
64 | MAP3K13 | 0.88341521 |
65 | PAK4 | 0.88234453 |
66 | ALK | 0.88142781 |
67 | STK4 | 0.88125166 |
68 | ZAP70 | 0.85511593 |
69 | KIT | 0.79754357 |
70 | CSNK2A2 | 0.79452973 |
71 | ARAF | 0.77266463 |
72 | CHEK1 | 0.76703086 |
73 | PKN2 | 0.75748323 |
74 | NUAK1 | 0.75634328 |
75 | MAP3K11 | 0.74680852 |
76 | EPHA2 | 0.74138494 |
77 | CSNK2A1 | 0.73498522 |
78 | MAPKAPK3 | 0.68447019 |
79 | BLK | 0.68238267 |
80 | PBK | 0.67975258 |
81 | EIF2AK2 | 0.67269374 |
82 | CCNB1 | 0.65533066 |
83 | RPS6KA5 | 0.63651402 |
84 | MAP3K3 | 0.63630166 |
85 | IKBKB | 0.62683898 |
86 | PTK6 | 0.62403919 |
87 | RIPK4 | 0.61779573 |
88 | PAK1 | 0.61243887 |
89 | ATM | 0.58037575 |
90 | BCKDK | 0.57510851 |
91 | SIK1 | 0.57502165 |
92 | CDK2 | 0.54902561 |
93 | NLK | 0.54663065 |
94 | TXK | 0.54112745 |
95 | JAK3 | 0.53996470 |
96 | CLK1 | 0.53550538 |
97 | MTOR | 0.52490687 |
98 | IRAK4 | 0.49302514 |
99 | TESK1 | 0.48291359 |
100 | PRKCI | 0.47589304 |
101 | MAP2K2 | 0.46862352 |
102 | TAOK2 | 0.46623379 |
103 | CSNK1E | 0.46180721 |
104 | ERN1 | 0.45938683 |
105 | AKT2 | 0.44829486 |
106 | TYK2 | 0.44012681 |
107 | BMPR2 | 0.42965034 |
108 | KSR2 | 0.42128480 |
109 | BRAF | 0.41807059 |
110 | MAP2K6 | 0.40931146 |
111 | NEK9 | 0.40187274 |
112 | CSF1R | 0.39850528 |
113 | FGFR4 | 0.39623148 |
114 | RAF1 | 0.38854052 |
115 | RPS6KA6 | 0.37953718 |
116 | RPS6KL1 | 0.37529671 |
117 | RPS6KC1 | 0.37529671 |
118 | CDK6 | 0.36722775 |
119 | LYN | 0.36348394 |
120 | SYK | 0.36248296 |
121 | MARK3 | 0.36200533 |
122 | RPS6KB1 | 0.34372968 |
123 | DAPK3 | 0.33530474 |
124 | STK3 | 0.33470830 |
125 | PAK2 | 0.30580471 |
126 | MYLK | 0.30188228 |
127 | CDK1 | 0.29974338 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Ribosome_Homo sapiens_hsa03010 | 6.14367469 |
2 | DNA replication_Homo sapiens_hsa03030 | 4.60995825 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 3.89366438 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.40772672 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 3.32510736 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.10098637 |
7 | Spliceosome_Homo sapiens_hsa03040 | 3.08697998 |
8 | Homologous recombination_Homo sapiens_hsa03440 | 2.90281270 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.76353024 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.68002987 |
11 | RNA transport_Homo sapiens_hsa03013 | 2.52154532 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.51799203 |
13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.13536579 |
14 | Cell cycle_Homo sapiens_hsa04110 | 2.00739721 |
15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.94430469 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85459258 |
17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.82627664 |
18 | RNA degradation_Homo sapiens_hsa03018 | 1.70258804 |
19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.66677902 |
20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.63508783 |
21 | Protein export_Homo sapiens_hsa03060 | 1.62645614 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60191739 |
23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39791857 |
24 | Purine metabolism_Homo sapiens_hsa00230 | 1.29948708 |
25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28830871 |
26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24391975 |
27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.21452028 |
28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17661319 |
29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07492702 |
30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07317390 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05004766 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99781582 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99278208 |
34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95230687 |
35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91559320 |
36 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90372073 |
37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87877989 |
38 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87088395 |
39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84718470 |
40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77070787 |
41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75850573 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74844665 |
43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74714014 |
44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68805048 |
45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66984654 |
46 | Legionellosis_Homo sapiens_hsa05134 | 0.65147330 |
47 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63153651 |
48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60602677 |
49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59178943 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58983970 |
51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56804312 |
52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56797439 |
53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56447436 |
54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56324636 |
55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54985947 |
56 | Measles_Homo sapiens_hsa05162 | 0.54809231 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52719904 |
58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52307492 |
59 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52153851 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50993455 |
61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49543582 |
62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49059046 |
63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48604494 |
64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48460633 |
65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47480010 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.43858279 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43055736 |
68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42810743 |
69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42620944 |
70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40239430 |
71 | Allograft rejection_Homo sapiens_hsa05330 | 0.39244222 |
72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37877322 |
73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37414215 |
74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37315036 |
75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36286546 |
76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35879691 |
77 | Asthma_Homo sapiens_hsa05310 | 0.35787243 |
78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33853139 |
79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32996322 |
80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32851824 |
81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32466709 |
82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32154656 |
83 | Alcoholism_Homo sapiens_hsa05034 | 0.31155578 |
84 | Hepatitis B_Homo sapiens_hsa05161 | 0.30661036 |
85 | Shigellosis_Homo sapiens_hsa05131 | 0.30646886 |
86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28924708 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28494469 |
88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28407025 |
89 | Influenza A_Homo sapiens_hsa05164 | 0.27851380 |
90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27478997 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26947318 |
92 | Prostate cancer_Homo sapiens_hsa05215 | 0.26337378 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25760142 |
94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25160252 |
95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23844849 |
96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.23802455 |
97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23286051 |
98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.22802695 |
99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22290251 |
100 | Lysine degradation_Homo sapiens_hsa00310 | 0.20816066 |
101 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20526033 |
102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20425373 |
103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20193963 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.19953268 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19581109 |
106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19149136 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18887082 |
108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17746171 |
109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17371768 |
110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.17050719 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16785656 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16496919 |
113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16374330 |
114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15566755 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15534134 |
116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.14830584 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14743164 |
118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.14002361 |
119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.13877138 |
120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13846683 |
121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13787387 |
122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.13214889 |
123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12263561 |
124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.12255705 |
125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12248151 |
126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11004387 |
127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.09885676 |